News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
129 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (140)
2 (87)
3 (116)
8 (97)
9 (103)
10 (87)
11 (120)
12 (60)
13 (2)
15 (95)
16 (129)
17 (108)
18 (127)
19 (62)
22 (109)
23 (101)
24 (100)
25 (141)
26 (76)
29 (161)
30 (127)
31 (159)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
8
9
10
11
12
13
15
16
17
18
19
22
23
24
25
26
29
30
31
Funding
Novo Holdings Leads $100M Raise for Asceneuron’s Alzheimer’s Push
Asceneuron, which develops small molecules targeting tau protein aggregation, plans to use the funds to advance its Alzheimer’s disease asset into Phase II.
July 16, 2024
·
1 min read
·
Tyler Patchen
Manufacturing
CordenPharma Expands GLP-1 Manufacturing Footprint in US and Europe with $980M Commitment
To help keep pace with the demand for GLP-1 therapies, CordenPharma has announced a sizeable $980 million investment in its U.S. and European sites.
July 16, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Lilly’s Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer’s Disease
July 16, 2024
·
16 min read
Business
Alignment Healthcare to Announce Second Quarter 2024 Financial Results and Host Conference Call Thursday, Aug. 1, 2024
July 16, 2024
·
1 min read
Business
Venus Concept to Release Second Quarter of Fiscal Year 2024 Financial Results on August 13, 2024
July 16, 2024
·
1 min read
Press Releases
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
July 16, 2024
·
3 min read
Press Releases
Abivax Provides Operational and Key Program Update
July 16, 2024
·
14 min read
Press Releases
Kyverna’s KYV-101 Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Refractory Stiff-Person Syndrome
July 16, 2024
·
5 min read
Press Releases
argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China
July 16, 2024
·
9 min read
Press Releases
CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe
July 16, 2024
·
5 min read
Previous
2 of 13
Next
